GR80853B - Kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical compositions suitable therefor - Google Patents
Kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical compositions suitable thereforInfo
- Publication number
- GR80853B GR80853B GR80853A GR840180853A GR80853B GR 80853 B GR80853 B GR 80853B GR 80853 A GR80853 A GR 80853A GR 840180853 A GR840180853 A GR 840180853A GR 80853 B GR80853 B GR 80853B
- Authority
- GR
- Greece
- Prior art keywords
- kit
- inhalation
- derivatives
- pharmaceutical compositions
- compositions suitable
- Prior art date
Links
- 150000002270 gangliosides Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- -1 ester ganglioside Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT8349288A IT1212896B (it) | 1983-11-08 | 1983-11-08 | Metodo di somministrazione per via inalatoria di gangliosidi e derivati, e composizioni farmaceutiche relative |
Publications (1)
Publication Number | Publication Date |
---|---|
GR80853B true GR80853B (en) | 1985-02-26 |
Family
ID=11270228
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR80853A GR80853B (en) | 1983-11-08 | 1984-11-06 | Kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical compositions suitable therefor |
Country Status (22)
Country | Link |
---|---|
US (1) | US4639437A (el) |
EP (1) | EP0145209B1 (el) |
JP (1) | JPS60132920A (el) |
KR (1) | KR850003503A (el) |
AT (1) | ATE47035T1 (el) |
AU (1) | AU569920B2 (el) |
BE (1) | BE900994A (el) |
CH (1) | CH662278A5 (el) |
DE (1) | DE3480053D1 (el) |
DK (1) | DK160129C (el) |
ES (1) | ES8608532A1 (el) |
FR (1) | FR2554346B1 (el) |
GR (1) | GR80853B (el) |
IL (1) | IL73292A (el) |
IN (1) | IN163563B (el) |
IT (1) | IT1212896B (el) |
LU (1) | LU85633A1 (el) |
MX (1) | MX163574B (el) |
NO (1) | NO844443L (el) |
NZ (1) | NZ209974A (el) |
PT (1) | PT79466B (el) |
ZA (1) | ZA848541B (el) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1177863B (it) * | 1984-07-03 | 1987-08-26 | Fidia Farmaceutici | Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche |
JPS6368526A (ja) * | 1986-09-11 | 1988-03-28 | Mect Corp | シアリルグリセライドからなる神経障害疾患治療剤 |
US4937232A (en) * | 1986-09-15 | 1990-06-26 | Duke University | Inhibition of protein kinase C by long-chain bases |
US4816450A (en) * | 1986-09-15 | 1989-03-28 | Duke University | Inhibition of protein kinase C by long-chain bases |
IT1212041B (it) * | 1987-11-02 | 1989-11-08 | Fidia Farmaceutici | Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche |
US5073543A (en) * | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
US6407061B1 (en) * | 1989-12-05 | 2002-06-18 | Chiron Corporation | Method for administering insulin-like growth factor to the brain |
DE69031279T2 (de) * | 1989-12-05 | 1998-03-19 | Ramsey Foundation | Neurologische wirkstoffe zur nasalen verabreichung an das gehirn |
US5624898A (en) * | 1989-12-05 | 1997-04-29 | Ramsey Foundation | Method for administering neurologic agents to the brain |
IT1249034B (it) * | 1990-06-29 | 1995-02-11 | Fidia Spa | Impiego del monosialoganglioside gm1 e del suo derivato estere interno per impedire l'instaurarsi della tolleranza nell'uomo all'effetto analgesico della morfina e analoghi |
WO1992017189A1 (en) * | 1991-03-29 | 1992-10-15 | The Regents Of The University Of California | Gangliosides with immunosuppressive activity |
WO1993002686A1 (en) * | 1991-07-31 | 1993-02-18 | The Regents Of The University Of California | Gangliosides with immunosuppressive ceramide moieties |
US5567684A (en) * | 1994-09-14 | 1996-10-22 | The Regents Of The University Of California | Synthetic ganglioside derivatives |
US7273618B2 (en) * | 1998-12-09 | 2007-09-25 | Chiron Corporation | Method for administering agents to the central nervous system |
JP2005527467A (ja) | 2001-08-29 | 2005-09-15 | ネオーズ テクノロジーズ, インコーポレイテッド | 新規な合成ガングリオシド誘導体およびその組成物 |
MXPA05009480A (es) | 2003-03-06 | 2006-02-22 | Neose Technologies Inc | Metodos y composiciones para la sintesis enzimatica de gangliosidos. |
CU23317A1 (es) | 2005-07-22 | 2008-10-22 | Ct De Investigacia N Y Desarro | Formulaciones nasales de eporh con bajo contenido de ã cido siã lico para el tratamiento de enfermedades del sistema nervioso central |
EP3175857A1 (en) | 2009-03-25 | 2017-06-07 | Seneb Biosciences Inc. | Glycolipids as treatment for disease |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL262354A (el) * | 1960-03-17 | |||
US3282781A (en) * | 1960-11-25 | 1966-11-01 | Merck & Co Inc | Inhalant compositions |
US4094968A (en) * | 1972-09-06 | 1978-06-13 | Burroughs Wellcome Co. | Treatment for allergy and method of composition thereof |
GB1571629A (en) * | 1977-11-30 | 1980-07-16 | Fisons Ltd | Pharmaceutical compositions containing beclomethasone dipropionate |
US4476119A (en) * | 1981-08-04 | 1984-10-09 | Fidia S.P.A. | Method for preparing ganglioside derivatives and use thereof in pharmaceutical compositions |
-
1983
- 1983-11-08 IT IT8349288A patent/IT1212896B/it active
-
1984
- 1984-04-12 US US06/599,340 patent/US4639437A/en not_active Expired - Fee Related
- 1984-10-23 DK DK505584A patent/DK160129C/da not_active IP Right Cessation
- 1984-10-23 IL IL73292A patent/IL73292A/xx unknown
- 1984-10-24 NZ NZ209974A patent/NZ209974A/en unknown
- 1984-10-26 IN IN750/CAL/84A patent/IN163563B/en unknown
- 1984-10-26 DE DE8484307403T patent/DE3480053D1/de not_active Expired
- 1984-10-26 AT AT84307403T patent/ATE47035T1/de not_active IP Right Cessation
- 1984-10-26 EP EP84307403A patent/EP0145209B1/en not_active Expired
- 1984-10-31 ES ES537300A patent/ES8608532A1/es not_active Expired
- 1984-11-01 ZA ZA848541A patent/ZA848541B/xx unknown
- 1984-11-06 GR GR80853A patent/GR80853B/el unknown
- 1984-11-06 MX MX203300A patent/MX163574B/es unknown
- 1984-11-06 FR FR8416859A patent/FR2554346B1/fr not_active Expired
- 1984-11-07 BE BE1/011131A patent/BE900994A/nl not_active IP Right Cessation
- 1984-11-07 AU AU35189/84A patent/AU569920B2/en not_active Ceased
- 1984-11-07 JP JP59235934A patent/JPS60132920A/ja active Granted
- 1984-11-07 NO NO844443A patent/NO844443L/no unknown
- 1984-11-07 PT PT79466A patent/PT79466B/pt not_active IP Right Cessation
- 1984-11-07 LU LU85633A patent/LU85633A1/fr unknown
- 1984-11-07 CH CH5339/84A patent/CH662278A5/fr not_active IP Right Cessation
- 1984-11-08 KR KR1019840006985A patent/KR850003503A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
LU85633A1 (fr) | 1985-06-04 |
IN163563B (el) | 1988-10-08 |
IT1212896B (it) | 1989-11-30 |
EP0145209A3 (en) | 1986-11-26 |
ATE47035T1 (de) | 1989-10-15 |
PT79466A (en) | 1984-12-01 |
PT79466B (en) | 1986-12-12 |
EP0145209A2 (en) | 1985-06-19 |
NO844443L (no) | 1985-05-09 |
DK160129B (da) | 1991-02-04 |
IL73292A0 (en) | 1985-01-31 |
ZA848541B (en) | 1985-06-26 |
DK160129C (da) | 1991-07-01 |
FR2554346B1 (fr) | 1987-11-20 |
FR2554346A1 (fr) | 1985-05-10 |
DK505584A (da) | 1985-05-09 |
IL73292A (en) | 1988-07-31 |
JPH0211570B2 (el) | 1990-03-14 |
MX163574B (es) | 1992-06-02 |
EP0145209B1 (en) | 1989-10-11 |
AU569920B2 (en) | 1988-02-25 |
AU3518984A (en) | 1985-05-16 |
DE3480053D1 (en) | 1989-11-16 |
IT8349288A0 (it) | 1983-11-08 |
US4639437A (en) | 1987-01-27 |
NZ209974A (en) | 1987-02-20 |
BE900994A (nl) | 1985-05-07 |
ES537300A0 (es) | 1986-07-16 |
CH662278A5 (fr) | 1987-09-30 |
JPS60132920A (ja) | 1985-07-16 |
DK505584D0 (da) | 1984-10-23 |
KR850003503A (ko) | 1985-06-20 |
ES8608532A1 (es) | 1986-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3480053D1 (en) | A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor | |
UA41906C2 (uk) | Спосіб лікування неврологічних порушень, викликаних травмами | |
IL133585A0 (en) | Soluble prodrugs of paclitaxel | |
IL99699A0 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
JPS6485984A (en) | Methylenephosphonoalkylphosphinates, medicinal composition and therapy for abnormal calcium and phosphate metabolism | |
ZA848369B (en) | Pharmaceutical compositions containing bilobalid for the treatment of neuropathies | |
IL68456A0 (en) | Pharmaceutical compositions comprising perfluorohydrocarbons as vehicles | |
ES8400742A1 (es) | Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co. | |
SE8500996D0 (sv) | Method of treatment | |
GB2162748B (en) | Medicinal composition for the treatment or prevention of acne by oral administration | |
GB2204488B (en) | Pharmaceutical compositions for the treatment or prophylaxis of skin disorders | |
DE3380923D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen. | |
JPS5753475A (en) | Novel thiazolyl-2-oxamic acid derivative, manufacture and medicine containing same | |
ATE275953T1 (de) | 2,3 diaryl-1-benzopyrame zur behandlung von dermatitis | |
HUT73500A (en) | Use of benzydamine for producing pharmaceutical compositions for treatment of pathological conditions caused by tnf | |
PT950053E (pt) | Novos derivados de benzoilalquil-1,2,3,6-tetra-hidropiridinas | |
ZA896464B (en) | Use of 2-azabicyclo(2.2.2)octane-3-carboxylic acid derivatives for the production of medicinal products intended for the treatment of diseases resulting from impairment of the vascular wall as well as for disorders of the microcirculation | |
IT8249521A0 (it) | Composizioni farmaceutiche contenenti idrossicicloesilammine da usare nel trattamento di malattie respiratorie | |
ZA897549B (en) | Medicament for the treatment of diseases caused by retroviruses | |
UA10093A (uk) | Спосіб лікування захворювань товстої кишки | |
ATE94758T1 (de) | Verwendung von gangliosiden zur behandlung der dysfunktion des autonomen nervensystems bei der chagas-krankheit. |